BREAKING: FDA approves the overdose reversal drug Narcan for over-the-counter use amid the ongoing opioid epidemic.
A box of the opioid antidote Naloxone, also known as Narcan, sits on display during a family addiction support group on March 23, 2016 in Groton, Conn.The U.S.
Food and Drug Administration approved the overdose reversal drug Narcan for over-the-counter use on Wednesday-- a milestone decision that advocates said will make it easier to save lives amid the ongoing opioid epidemic.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves over-the-counter sales of lifesaving opioid overdose treatment Narcan nasal sprayThe FDA's decision means people will be able to buy the 4mg nasal spray without a prescription in supermarkets, convenience stores and vending machines.
Read more »
FDA approves over-the-counter Narcan; here’s what it meansThe U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.
Read more »
Can Over-the-Counter Narcan Put an End to Opioid Deaths?Making Narcan over-the-counter would be a step in the right direction, public health experts told The Daily Beast—but they question how much impact it will actually have in stemming the tide of opioid overdose deaths.
Read more »
Fighting Fentanyl: Local class teaches community members to save lives with NarcanNarcan is a powerful tool in the fight against fentanyl, and a local treatment center in San Antonio is showing people how to administer it to help save lives.
Read more »
Drug overdose antidote Narcan goes over-the-counterThe FDA move allows retailers to sell the nasal spray without a prescription, but experts worry the price may still discourage some buyers.
Read more »
FDA knew about latest baby formula problem months before recallFDA inspectors knew about contamination at the Enfamil plant in November, three months before the recall.
Read more »